Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients ...

Current severity assessment tools, such as the Psoriasis Area and Severity Index (PASI), have limitations. However, ML may offer promising advancements by enhancing disease stratification and ...

A new study aimed to explore the role of stress hyperglycemia ratio (SHR) in predicting mortality risks for patients with ...

Arthritis is a common acute or chronic condition affecting the joints and surrounding tissues. It’s estimated that roughly 18 ...

If you're being treated for hives, your physician will want to hear what you think about your treatment. Is it working? Are your symptoms improving, staying the same, or getting worse? You may be ...

In commemoration of World Psoriasis Day 2024 on November 2, the Psoriasis Association of Ghana (PAG) held an awareness walk and educational forum themed ldquo;Psoriasis and the Family rdquo; .

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

and collaborate with dermatologists on how to best manage psoriasis without disrupting cancer treatment," Marmon told MedPage Today. The mechanism behind an ICI-psoriasis link is unknown, Kao and ...

Psoriasis is a chronic autoimmune skin condition that causes patches of thick, red, scaly skin. Usually, the elbows, knees, ...

The future of dermatology depends on innovative treatments like VTAMA, and Organon’s acquisition of Dermavant allows us to ...

VTAMA ® (tapinarof) cream, 1%, is a novel nonbiologic, non-steroidal topical therapy approved by the U.S. Food and Drug Administration (FDA) for treatment of mild, moderate, and severe plaque ...